Harmful algal blooms (HABs) are a worldwide problem with substantial adverse effects on the aquatic environment as well as human health, which have prompted researchers to study measures to stem and control them. Meanwhile, it is key to research and develop monitoring methods to establish early warning HABs. However, both the current monitoring methods and control methods have some shortcomings, making the field application limited. Thus, we need to improve current approaches for monitoring and controlling HABs efficiently. Based on the freshwater system features in China, we review various monitoring and control methods of HABs, summarize and discuss the problems with these methods, and propose the future development direction of monitoring and control HABs. Finally, we envision that it can combine physical, chemical, and biological methods to inhibit HAB expansion in the future, complementing each other with advantages. Further, we promise to establish a long-term strategy of controlling HABs with various algicidal bacteria co-cultivate for field applications in China. Efforts in studying algicidal bacteria must be increased to better control HABs and mitigate the risks of aquatic ecosystems and human health in China.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11356-022-21382-9 | DOI Listing |
Diabetes Obes Metab
January 2025
Department of Clinical and Biomedical Sciences, University of Exeter Medical School, Exeter, UK.
Aims: To assess outcomes of oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c), where specific treatment guidance is limited.
Materials And Methods: Using hospital-linked UK primary care records (Clinical Practice Research Datalink; 2004-2020), we identified 7084 people with a pancreatic condition (acute pancreatitis, chronic pancreatitis, pancreatic cancer and haemochromatosis) preceding diabetes diagnosis (type 3c cohort), initiating oral glucose-lowering therapy (metformin, sulphonylureas, SGLT2-inhibitors, DPP4-inhibitors or thiazolidinediones), and without concurrent insulin treatment. We stratified by pancreatic exocrine insufficiency [PEI] (nā=ā5917 without PEI, 1167 with PEI) and matched to 97ā227 type 2 diabetes (T2D) controls.
Anim Microbiome
January 2025
School of Pharmacy and Life Sciences, Robert Gordon University, Garthdee Road, Aberdeen, AB10 7GJ, UK.
Background: Cryptosporidiosis is a diarrheal disease that commonly affects calves under 6 weeks old. The causative agent, Cryptosporidium parvum, has been associated with the abundance of specific taxa in the faecal microbiome during active infection. However, the long-term impact of these microbiome shifts, and potential effects on calf growth and health have not yet been explored in depth.
View Article and Find Full Text PDFMol Cancer
January 2025
Department of Hematology, Qilu Hospital of Shandong University, No.117, West of Wenhua Road, Jinan, Shandong, 250012, People's Republic of China.
Background: Drug resistance and immune escape continue to contribute to poor prognosis in AML. Increasing evidence suggests that exosomes play a crucial role in AML immune microenvironment.
Methods: Sanger sequencing, RNase R and fluorescence in situ hybridization were performed to confirm the existence of circ_0006896.
BMC Nurs
January 2025
Department of Nursing, Bandar Gaz Branch, Islamic Azad University, Bandar Gaz, Iran.
Background: Supportive care has been found to improve quality of life and reduce the disease burden for aging individuals. After a heart attack, elderly patients often require a caregiver. In developing communities, caregiving responsibilities frequently fall on family members.
View Article and Find Full Text PDFArch Virol
January 2025
CAS Key Laboratory of Molecular Virology & Immunology, Institutional Center for Shared Technologies and Facilities, Pathogen Discovery and Big Data Platform, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Yueyang Road 320, Shanghai, 200031, China.
To battle seasonal outbreaks of influenza B virus infection, which continue to pose a major threat to world health, new and improved vaccines are urgently needed. In this article, we discuss the current state of next-generation influenza B vaccine development, including both advancements and challenges. This review covers the shortcomings of existing influenza vaccines and stresses the need for more-effective and broadly protective vaccines and more-easily scalable manufacturing processes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!